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therapy.
Materials and methods: This prospective study were performed on 20 consecutive female patients,
from January 2008 till January 2010 at Zagazig university hospitals. All cases had undergone breast
conservative therapy (BCT) at least 9–12 months since the end of radiation therapy up to 5 years.
All cases were suspected for either recurrence or post-operative complications by clinical examina-
tion in conjunction with mammography or/and US. DCE-MRM was performed at 1.5 T. The ﬁnd-
ings were correlated with the histopathology in all cases.
Results: We found that DCE-MRM accurately revealed the presence or absence, location, and
extent of recurrent tumor more accurately than mammography or US. US had high sensitivity
and speciﬁcity (85.7% and 76.8%) compared to mammography (71.4% and 38.4%, respectively).
Seven recurrent cases were found, two of them were multifocal. False-positive contrast enhancement
was seen in only one patient pathologically proved as granuloma. MRI showed 95% accuracy, 100%partment of Radiodiagnosis,
asaken, Sharkia, Egypt. Tel.:
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470 D.I. Hasan et al.sensitivity, 92.3% speciﬁcity with 83% positive predictive value and 100% negative predictive value.
Conclusion: The conventional imaging was insufﬁcient to detect the recurrent lesions after BCT, so
DCE-MRI should be the imaging modality of choice in detection of the tumoral recurrence, and dif-
ferentiating it from other complications. One limitation of the DCE-MRM is the persistent false-
positive enhancement due to granulation tissue.
 2010 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
All rights reserved.Fig. 1 Schematic drawing of the time–signal intensity curve
types. Type I (Benign lesions) a straight (Ia) or curved (Ib) line;
enhancement continues over the entire dynamic study. Type II
(both benign and malignant lesions) is a plateau curve with a sharp
bend after the initial upstroke. Type III (malignant lesions) is a
washout time course.1. Introduction
Breast-conserving therapy (BCT) is increasingly being inte-
grated into the management of breast cancer (1). BCT which
consists of lumpectomy alone or lumpectomy and axillary
lymph nodes dissection, or quadrectomy with axillary L.N dis-
section followed by breast irradiation, these considered the
standard of care for early-stage breast cancer (stages I and
II) and their results in survival equivalent to that observed
after mastectomy (2).
Post operative scarring may be severe, produces marked
architectural distortion, increases density on mammography,
and even an apparent mass. This causes signiﬁcant clinical
problems if the recurrent malignance is suspected (3,4).
The sensitivity for the diagnosis of local recurrence after
breast conserving treatment was shown to be 64–71% for
mammography, 81–85% for ultrasonography (5). Dynamic
contrast-enhanced magnetic resonance imaging (DCE-MRM)
plays important role in patients after breast conservation sur-
gery, since the rate of local recurrence ranges from 1% to 2–
3% per year even with radiotherapy (6,7).
MRI is useful for detecting multifocality and multicentrici-
ty of breast cancer, differentiating between scar tissue and
recurrent cancer after BCT (8). The dynamic enhancement pat-
tern, combined with morphology on contrast-enhanced MRI
of breast masses, allows reproducible lesion characterization
(9).
2. Patients and methods
This prospective study was performed on 20 consecutive fe-
male patients, from January 2008 till January 2010 at Zagazig
university hospitals. All cases had undergone BCT and least 9–
12 months since the end of radiation therapy up to 5 years. All
cases were suspected for either recurrence and post-operative
complications by clinical examination in conjunction with
mammography or/and US. DCE-MRM was performed at
1.5 T. (Philips Achieva, class II a) by using standard bilateral
dedicated breast coils. The imaging protocol consisted of axial,
coronal, and sagittal images of both breast. Precontrast T1W
frames were acquired in the axial plane (FSE; -ﬂip an-
gle = 90; TR = 9.9 ms; TE = 4.2 ms; NEX, 1; 2–3 mm slice
thickness with no. gap; 512 · 192 matrix, FVO = 35). Acqui-
sition of imaging started 10 s after the intravenous injection
of 0.2 mmol per/kg of gadopentetate dimeglumine (Gd-DTPA,
Magnevist; ﬂow rate 2 mL/s), imaging time with this frame was
approximately 80 s.
Axial T1 WIs fat suppression and subtracted images after
the DCE-series. A small region of interest (ROI > 3pixels)
was placed selectively over the most intensely enhancing area
of the lesion.The morphologic features were recorded: site, size, margins,
detection of multifocality, unifocal, skin involvement or lymph
node involvement and type of enhancement according to
(Fig. 1) the time–intensity curve (10,11).
Conﬁrmation of different lesions were achieved by ﬁne nee-
dle aspiration biopsy, core or excisional biopsy. The sensitiv-
ity, speciﬁcity, accuracy, +ve predictive value and -ve
predictive value of dynamic enhanced – MRM in the detection
of recurrent disease or post-operative and radiation sequels
were calculated by using student t-test.
3. Results
Twenty female patients were included in this study, their ages
ranged from 32 to 56 years (mean age 41.3 y). Five cases had
gone lumpectomy alone, lumpectomy with axillary dissection
in 11, and quadrectomy with axillary dissection in the remain-
ing 4 cases (18 underwent radiation). Mammography ﬁndings
suspected recurrence in 9 cases (3 of them had micro calciﬁca-
tions), while US suspected it in 7 cases only.
Post-operative collections (seromas) were clearly identiﬁed
in US examination, but mammography over estimates it as a
recurrence (two false positive cases). Skin thickening was
found focal in 6 cases and diffuse in 12 cases.
MRI morphological and kinematics ﬁndings for seven
recurrent cases (Table 1) were matched with the histopatholo-
gical data.
Table 2 Mammography, US, and DCE-MRI sensitivity,
speciﬁcity and accuracy.
Sensitivity (%) Speciﬁcity (%) Accuracy (%)
Mammography 71.4 38.4 50
US 85.7 76.9 80
DCE-MRI 100 92.3 95
Fig. 2 A 52-year-old patient with BCT of her left breast 3 years
previously. (A) MLO view showing increased parenchymal density
of the breast, no deﬁnite masses identiﬁed. (B) US shows an ill-
deﬁned hypoechoic mass (arrow) distant from the operation bed.
(C and D) Axial T1FS after DCE-series and time intensity curve,
showing intermediate heterogeneous enhanced mass (arrow) in the
upper outer quadrant of the left breast, time intensity curve
corresponding to a type III (rapid washout), true positive case.
Table 1 Histopathological types and MRM ﬁndings.
Histopathological
types
Invasive duct carcinoma (n= 4)
Lobular carcinoma (n= 2)
Duct carcinoma in situ (DCIS) (n= 1)
MRM ﬁndings n Location of the tumor-operation
bed
(n= 5)
– other sites (n= 2)
n Type of the lesion-Mass (n= 5)
– Foci (n= 2)
n Time intensity curve-Type III
(wash out)
(n= 6)
– Type II (plateau) (n= 1)
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enhancement in 8 cases while the remaining presented by mild
enhancement with characteristic slow wash in before the ﬁrst
90 s. In the 3 cases of post-operative seromas no enhancement
were detected while, one of them had rim enhancement. Mam-
mography, US, and DCE-MRI sensitivity, speciﬁcity and
accuracy (Table 2) DCE-MRM had 83%+ve predictive value
and 100% ve predictive value.
4. Discussion
The combination of conservative surgery, and radiation ther-
apy offers the additional advantage of preserving the breast
with a highly satisfactory cosmetic result (12,13). BCT will
leave patients with some risk of development of a new primary
tumor of the breast, or failure of the primary treatment as pa-
tients with early stages of invasive breast cancer mastectomy
does not guarantee local control.
When tumor recurs in a conservatively treated breast, it
may recur at the lumpectomy bed, adjacent to the marginal
or elsewhere in the breast (4). The ability of mammography
to show the tumor in the irradiated breast is somewhat com-
promised by the increased density, surgical deformity, and
dense breasts of young patients.
These are the reasons in our study for decreased mammog-
raphy sensitivity, and speciﬁcity (71.4% and 38.4%, respec-
tively), while microcalciﬁcations make diagnoses easily in 3
recurrent cases. Series carried by Dershaw et al. (14), in which
19 of 29 mammographically detected recurrences contained
microcalciﬁcations.
Assessment by US was valuable for recurrent masses
(Fig. 2B), and a reliable follow-up test was made if the mammo-
gram result is negative. In this study US recorded high sensitiv-
ity and speciﬁcity (85.7% and 76.8%) than mammography.
On the other hand problems were encountered with US be-
cause of hypoechoic areas, shadowing within the scar tissue,and fat necrosis (Fig. 3) which had a similar appearance to that
of breast lumps (15).
All previously mentioned reasons make the MRM a useful
additional examination in patient with suspected recurrence
(14,15). DCE-MRM in our study detected the recurrence
and differentiating it from non enhanced scar tissue which en-
hanced after the operation by 6 month without radiation and
up to 18 month after the radiotherapy.
In the present study all recurrent cases detected 7 out of
the all suspected cases. Multifocality were detected only by
MRI in 2 cases (5 in the surgical bed and 2 cases in other
sites), in accordance with Lorenzo et al. (15) that will inﬂuence
the type of suitable further surgery (quadrectomy versus
mastectomy).
In the current study one false positive case (Fig. 4) was
found as focal enhanced mass showing type III time–signal
intensity curve, and proved pathologically as a granuloma.
Similarly Lorenzo et al. (15) stated high false positive cases (se-
ven cases) in his research claimed it due to short post radiation
period (12 month).
The overall sensitivity of the DCE-MRM was 100% like
other studies (14,10). The speciﬁcity and accuracy in our study
were as follow 92.3%and 95%, respectively.
Fig. 3 A 43-year-old patient after BCT for her LT. Breast 18 month ago. (A) MLO view showing a spiculated border, indistinct margins,
mass at deep (retro mammary fat), and partially calciﬁed oil cyst at the upper outer quadrant. (B) US showing an ill-deﬁned of mixed
echogenicity mass. (C) Axial T1WI demonstrating central high signal intensity of the fat surrounded by hypointense wall with radiating
ﬁbrotic bands (long arrow), and typical oil cyst is seen (short arrow). (D and E) Axial T1 FS after DCE-series and time intensity curve
irregular enhanced wall type I in the surrounded inﬂammation around the fat necrosis.
Fig. 4 A 48-year-old patient with BCT for her RT. Breast 15 month ago. (A) MLO view showing suspicious lesion at the upper outer
quadrant. (B) US suggesting an ill-deﬁned hypoechoic mass extending under the scar line. (C) Axial T1 FS after DCE-series showing
heterogeneous focal mass enhancement in the upper outer quadrant of the left breast (arrow). (D) Time intensity curve corresponding to a
type III (rapid washout), which were false positive case proved by pathology as a granuloma.
472 D.I. Hasan et al.5. Conclusion
The conventional imaging with mammography and sonogra-
phy was insufﬁcient to detect the recurrent lesions afterBCT, so DCE-MRI should be the imaging modality of choice
in assessing the conservatively treated breasts as accurate
detection of the tumoral recurrence, and differentiating it from
other complications. High ve predictive value of the DCE-
The value of dynamic MRI in the evaluation of the breast following conservative surgery and radiotherapy 473MRM reduces unnecessary biopsies. One limitation of the
DCE-MRM is the persistent false-positive enhancement due
to granulation tissue.
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